|Overall Cartel Period||1992-2012|
|Total Fines (DOJ)||No fines imposed|
|Total Fines (EC)||No fines imposed|
In 1992, the Canadian Competition Bureau (“CCB”) launched investigations into Pfizer Inc.’s and Fujisawa Pharmaceutical Co., Ltd.’s sodium erythorbate manufacturing business. Sodium erythorbate is a chemical primarily used as a food preservative agent to maintain color and flavor in meat and other processed foods commonly sold in grocery stores. Between 1992 and 1994, no manufacturing or refining facilities for sodium erythorbate existed in Canada, and the $7.5 million CAD sales of the chemical consisted entirely of imports. Pfizer Inc. pled guilty to price-fixing in the Canadian market through its former Food Science Group. Pfizer has since divested the assets of the group and no longer produces the product.
- The CCB imposed a $1.5 million CAD fine on Pfizer Inc. for its anti-competitive conduct.
|Pfizer Inc.||$ 1.5 million||10/24/2001|